Who owns AbbVie Inc. (ABBV)? Elite investor 13F holders
14 tracked elite investors reported holding AbbVie Inc as of 2026-06-30, including D.E. Shaw, Ancora Advisors / Ancora Holdings, Gotham Asset Management, Torray Funds, Aristotle Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
14 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 529026798.00 USD | 2102316.000000 | Shares | add | Original filing |
| Ancora Advisors / Ancora Holdings | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 75631837.00 USD | 300556.000000 | Shares | reduce | Original filing |
| Tudor Investment | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Gotham Asset Management | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 27395292.00 USD | 108867.000000 | Shares | add | Original filing |
| Torray Funds | ABBVIE INC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 20785967.00 USD | 82602.000000 | Shares | reduce | Original filing |
| Aristotle Capital Management | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 16095901.00 USD | 63964.000000 | Shares | reduce | Original filing |
| Mairs & Power Funds | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 11248811.00 USD | 44702.000000 | Shares | reduce | Original filing |
| Matrix Asset Advisors | ABBVIE INC | SHARE | 2026-06-30 | 2026-07-15 00:00:00 | 9831624.00 USD | 39070.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2963061.00 USD | 11775.000000 | Shares | reduce | Original filing |
| GAMCO | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 3423059.00 USD | 13603.000000 | Shares | reduce | Original filing |
| Gardner Russo & Quinn | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 3122852.00 USD | 12410.000000 | Shares | hold | Original filing |
| Jensen Investment Management | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 2784145.00 USD | 11064.000000 | Shares | reduce | Original filing |
| Dodge & Cox Funds | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 2615295.00 USD | 10393.000000 | Shares | hold | Original filing |
| Oakmark Funds | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 608969.00 USD | 2420.000000 | Shares | reduce | Original filing |
| GMO | ABBVIE INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 222701.00 USD | 885.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.